Industry & CROs

We are a leading Contract Research Organization (CRO) that is designed to be an alternative to larger, conventional providers. We offer a comprehensive, personalized service portfolio that can be tailored to support preclinical research and phase 1-4 clinical trials. We provide high quality deliverables to our clients who enjoy the benefits of our proactive, specialized approach.

Key Features

Srvcs_disease

Disease Focused In Hematology / Oncology

We specialize in the design and conduct of hematology and oncology studies. We have expertise in many different cancer types with a special focus on multiple myeloma, breast and prostate cancers.

Our goal is to optimize the utility, efficacy and outcomes of drugs, diagnostics and the overall patient experience.

ServiceFeatures_CommunInvest

Prioritize Community Investigators & Sites

Our strategic focus is on top notch community oncology investigators and sites.

Working with community size allows us to reach a robust cohort of real-world patients for relevant, representative, and translatable outcomes.

Srvcs_Focus

Focused To Maintain Strategic Efficiency

Conventional CROs traditionally have inflated overheads.

In contrast, we tailor the delivery of targeted resources and services specified by our clients to optimize value and the customer experience.

Program Features

PrgmFtr_Trmnt_Opt

Treatment Optimization

Developing existing cancer treatment regimens in addition to novel promising drugs leading to improved patient outcomes

PrgmFtr_Trmnt_DrugAccess

Drug Accessibilty

Providing community clinicians and patients with access to novel agents in development that are usually reserved for investigation by academic institutions.

PrgmFtr_Trmnt_AccelCare

Accelerating Care

Advancing the development and adoption of life-altering therapies, thereby providing new options that can extend survival and improve quality of life for patients living with cancer.

Programs_ClinicalSample

Clinical Sample Collections & Analysis

+ Retrospective

GLP compliant biobank with thousands of characterized human samples

Learn more about ONCOtracker biospecimens here.

+ Prospective

ONCOCAPTURE = ONCOtherapeutics Collection and Archiving Program to support Research Endeavors

oncocapture_white

ONCOCAPTURE

ONCOtherapeutics Collection and Archiving Program to Support Research Endeavors

+ Retrospective

Collaboration with GLP compliant biobank with thousands of characterized human samples

Learn more about ONCOtracker biospecimens here

+ Prospective

Master sample collection protocol to accommodate a multitude of different disease and tumor types

Our Process

OncoThera_Assets_Master_Step1

Collaboration, Consideration & Proposal

OncoThera_Assets_Master_Need_Generation
  • Company Sponsored Trial (CST)
  • Investigator initiated idea (ISS/IIT) identified by Onco
OncoThera_Assets_Master_Initial_Consideration
  • CST: Industry evaluates Oncotherapeutics capabilities against other CROs
  • IIT: Oncotherapeutics presents initial ISS/IIT written concept for consideration
OncoThera_Assets_Master_Step2

Development Of Concept

OncoThera_Assets_Master_Idea_Concept_Development
  • CST: Provides concept or protocol to review and evaluation of proposed budget
  • IIT: Synopsis development and budget proposal
OncoThera_Assets_Master_Negotiations
  • CST/IIT: Review, evaluation, budget negotiations and agreement of project financial stipulations
OncoThera_Assets_Master_Step3

Protocol Development, Regulatory Submissions & Project Management

OncoThera_Assets_Master_Protocol_Devlopment
  • CST: Receive industry designed study for review and to provide feedback
  • IIT: Full design of protocol and submission for company evaluation and approval
OncoThera_Assets_Master_Regulatory_Submission
  • CST/IIT: IRB and appropriate regulatory agency submission for approval
  • Collection of documents and arrange trial master file (TMF) and EDC development
OncoThera_Assets_Master_Site_Contracting
  • CST/IIT: Site identification and evaluation through site qualification questionnaire
  • Site selection, site budget and contracting negotiations
OncoThera_Assets_Master_Maintenance_Progress
  • CST/IIT: Ongoing study support, medical and regulatory monitoring
OncoThera_Assets_Master_Step4

Recruitment, Results & Publications

OncoThera_Assets_Master_Recruitment
  • CST/IIT: Facilitate patient recruitment. Evaluation of study performance, recruitment plan and metrics
OncoThera_Assets_Master_Data_Collection_Analysis
  • CST/IIT: Ongoing data collection, query resolution and data review
OncoThera_Assets_Master_Study_Closure
  • CST/IIT: Final data extraction, monitoring, review and analysis
  • Abstract / manuscript / publication

Streamline Your Protocol Today

See how our clinical-trial services can streamline your protocol, shortening the time to move your drug from conception to regulatory and marketing approval, while dramatically reducing cost.

Active Clinical Studies

View Studies